What is the CVSS score of CVE-2021-29868?

CVE-2021-29868 has a CVSS 3.1 base score of 5.5 (Medium). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.2%.

Is there a patch available for CVE-2021-29868?

Yes, a patch is available for CVE-2021-29868. Update the affected software to the latest version immediately.

I2 Ibase CVE-2021-29868

MEDIUM

Insufficient Session Expiration (CWE-613)

2021-10-27 psirt@us.ibm.com

IBM Information Disclosure I2 Ibase

5.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

5.5 MEDIUM

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Oct 27, 2021 - 16:15 nvd

MEDIUM 5.5

DescriptionNVD

IBM i2 iBase 8.9.13 and 9.0.0 could allow a local attacker to obtain sensitive information due to insufficient session expiration. IBM X-Force ID: 206213.

AnalysisAI

IBM i2 iBase 8.9.13 and 9.0.0 could allow a local attacker to obtain sensitive information due to insufficient session expiration. Rated medium severity (CVSS 5.5), this vulnerability is low attack complexity.

Technical ContextAI

This vulnerability is classified under CWE-613. IBM i2 iBase 8.9.13 and 9.0.0 could allow a local attacker to obtain sensitive information due to insufficient session expiration. IBM X-Force ID: 206213. Affected products include: Ibm I2 Ibase.

RemediationAI

A vendor patch is available. Apply the latest security update as soon as possible. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.